Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Emergency contraception

Diana Hsiang and Sheila Dunn
CMAJ December 06, 2016 188 (17-18) E536; DOI: https://doi.org/10.1503/cmaj.160720
Diana Hsiang
Department of Family and Community Medicine (Hsiang, Dunn), Women’s College Hospital, University of Toronto; Women’s College Research Institute (Dunn), Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Diana.Hsiang@wchospital.ca
Sheila Dunn
Department of Family and Community Medicine (Hsiang, Dunn), Women’s College Hospital, University of Toronto; Women’s College Research Institute (Dunn), Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Emergency contraception should be considered for women at risk of unintended pregnancy after unprotected intercourse

There are two methods of emergency contraception: the copper intrauterine device and hormonal emergency contraception using levonorgestrel (a progestin) or ulipristal acetate (a selective progesterone receptor modulator). All methods act before implantation (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.160720/-/DC1).1

The copper intrauterine device is the most effective method and a first-line option for most women

The copper intrauterine device is 99.9% effective when used within seven days of unprotected intercourse. 2 It is suitable for most women, including those who have never given birth and adolescents. Contraindications are the same as when used for regular contraception. Testing for sexually transmitted infection can be done at time of insertion of the device.

Hormonal emergency contraception is easier to access but less effective than the copper intrauterine device

Although most effective when taken immediately, both levonorgestrel and ulipristal have some effect if taken up to five days after unprotected intercourse.2 Ulipristal is somewhat more effective than levonorgestrel, with pregnancy rates of 1.3% v. 2.2%, respectively, when used within 120 hours of intercourse.2,4 Use of ulipristal is not recommended in women using emergency contraception because of missed hormonal contraception.3

An elevated body mass index may decrease the effectiveness of hormonal emergency contraception but has no impact on the copper intrauterine device

Although still being studied, levonorgestrel may be less effective in patients with a body mass index (BMI) of 25 kg/m2 or more, whereas ulipristal appears to be effective in patients with a BMI up to 35 kg/m2.2,5 If a copper intrauterine device is not an option, hormonal emergency contraception should be offered regardless of BMI (preferably ulipristal).

Women using hormonal emergency contraception need a plan for ongoing contraception

Hormonal contraception can be started immediately after levonorgestrel; however, it should be delayed until five days after use of ulipristal to not interfere with the action of ulipristal. 2 Back-up contraception is needed until hormonal contraception has been used for seven days.2,3 In the absence of menses within three to four weeks after emergency contraception, pregnancy should be excluded. (Patient information on emergency contraception is available at www.whatsnextforme.ca).

Acknowledgement

The authors thank Dr. Edith Guilbert and the Women’s College Hospital Family Medicine Peer Support Writing Group for their guidance in the production of this article.

Footnotes

  • Competing interests: Sheila Dunn is a coauthor of the emergency contraception chapter of the Canadian Contraceptive Consensus published in 2015. No other competing interests were declared.

  • This article has been peer reviewed.

References

  1. ↵
    1. Gemzell-Danielsson K,
    2. Berger C,
    3. Lalitkumar PG
    . Emergency contraception — mechanisms of action. Contraception 2013;87:300–8.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Black A,
    2. Guilbert E,
    3. Costescu D,
    4. et al
    . Canadian Contraceptive Consensus (part 1 of 4). J Obstet Gynaecol Can 2015;37:936–42.
    OpenUrl
  3. ↵
    1. Guilbert E,
    2. Dunn S,
    3. Black A
    . Addendum to the Canadian Consensus on Contraception — Emergency contraception: 1) Excluding pre-existing pregnancy when inserting copper IUD and 2) Initiation of hormonal contraception after emergency contraception. J Obstet Gynaecol Can 2016 Oct. 13. DOI:http://dx.doi.org/10.1016/j.jogc.2016.08.005.
  4. ↵
    1. Glasier AF,
    2. Cameron ST,
    3. Fine PM,
    4. et al
    . Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis. Lancet 2010;375:555–62.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Trussell J,
    2. Cleland K
    . Emergency contraceptive pill efficacy and BMI/body weight. Princeton (NJ): Office of Population Research, Princeton University; 2014. Available: www.contraceptivetechnology.org/latebreakers/emergencycontraceptive-pill-efficacy-bmibody-weight/ (accessed 2016 June 17).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (17-18)
CMAJ
Vol. 188, Issue 17-18
6 Dec 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Emergency contraception
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Emergency contraception
Diana Hsiang, Sheila Dunn
CMAJ Dec 2016, 188 (17-18) E536; DOI: 10.1503/cmaj.160720

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Emergency contraception
Diana Hsiang, Sheila Dunn
CMAJ Dec 2016, 188 (17-18) E536; DOI: 10.1503/cmaj.160720
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Emergency contraception should be considered for women at risk of unintended pregnancy after unprotected intercourse
    • The copper intrauterine device is the most effective method and a first-line option for most women
    • Hormonal emergency contraception is easier to access but less effective than the copper intrauterine device
    • An elevated body mass index may decrease the effectiveness of hormonal emergency contraception but has no impact on the copper intrauterine device
    • Women using hormonal emergency contraception need a plan for ongoing contraception
    • Acknowledgement
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
  • Radiation dermatitis in a patient treated for hepatocarcinoma
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Drugs: hormones & metabolic agents
    • Emergency medicine
    • Family medicine, general practice, primary care
    • Medical devices
    • Sexual health
    • Women's health (including abortion)

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire